Dr Sion Coulman
Senior Lecturer
Trosolwyg
Aelod o’r Tîm Darganfod Cyffuriau, y Gwyddorau Fferyllol a Therapiwteg Arbrofol yn Ysgol Fferylliaeth a Gwyddorau Fferyllol Prifysgol Caerdydd
Rwy'n ymchwilydd cydweithredol iawn sy'n arwain ac yn cyfrannu at dimau rhyngddisgyblaethol o gydweithwyr gwyddonol a chlinigol o gefndir academaidd a chefndir masnachol, ac mae gennyf ddiddordeb angerddol mewn sicrhau bod ymchwil wyddonol yn cael effaith amlwg. Mae fy nghefndir addysgol a phroffesiynol ym maes fferylliaeth a’r gwyddorau fferyllol. Mae fy ngweithgareddau ymchwil presennol yn ymwneud â’r croen (fel organ a rhwystr) ac optimeiddio systemau cyflwyno cyffuriau arloesol.
- PhD (Cyflwyno Cyffuriau), Prifysgol Caerdydd, 2007
- MPharm, Prifysgol Cymru, Caerdydd, 2001
Cyhoeddiad
2023
- Moukachar, A. et al. 2023. Development and evaluation of a low‐cost lego 3d bioprinter: from building‐blocks to building blocks of life. Advanced Materials Technologies 8(6), article number: 2100868. (10.1002/admt.202100868)
2022
- Potts, M. R., Evans, S. L., Pullin, R., Coulman, S. A., Birchall, J. C. and Wyatt, H. 2022. An analysis of the relationship between microneedle spacing, needle force and skin strain during the indentation phase prior to skin penetration. Computer Methods in Biomechanics and Biomedical Engineering (10.1080/10255842.2022.2136486)
- Al Dalaty, A., Gualeni, B., Coulman, S. A. and Birchall, J. C. 2022. Models and methods to characterise levonorgestrel release from intradermally administered contraceptives. Drug Delivery and Translational Research 12, pp. 335-349. (10.1007/s13346-021-01091-5)
- Tatovic, D. et al. 2022. Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in Type 1 diabetes. Immunotherapy Advances 2(1), article number: ltac002. (10.1093/immadv/ltac002)
2021
- Gualeni, B. et al. 2021. Human-centred design of a new microneedle-based hormonal contraceptive delivery system [version 2; peer review: 2 approved with reservations]. Gates Open Research 5, article number: 96. (10.12688/gatesopenres.13233.2)
- Singh, R. K. et al. 2021. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides. Nanomedicine: Nanotechnology, Biology and Medicine 32, article number: 102321. (10.1016/j.nano.2020.102321)
2020
- Arikat, F. et al. 2020. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes. Journal of Controlled Release 322, pp. 593-601. (10.1016/j.jconrel.2020.02.031)
2019
- Dul, M. et al. 2019. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy. International Journal of Pharmaceutics 562, pp. 303-312. (10.1016/j.ijpharm.2019.03.041)
2018
- Prytherch, Z. et al. 2018. Evaluation of student engagement with differential media for Flipped Classroom teaching. Presented at: EdMedia: World Conference on Educational Media and Technology, Amsterdam, 25-29 June 2018 Presented at Bastiaens, T. et al. eds.Proceedings of EdMedia: World Conference on Educational Media and Technology. Amsterdam, The Netherlands: Association for the Advancement of Computing in Education (AACE) pp. 1923-1928.
- Gualeni, B. et al. 2018. Minimally-invasive and targeted therapeutic cell delivery to the skin using microneedle devices. British Journal of Dermatology 178(3), pp. 731-739. (10.1111/bjd.15923)
- Davies, L., Gateley, C., Holland, P., Coulman, S. and Birchall, J. 2018. Accelerating topical anaesthesia using microneedles. Skin Pharmacology and Physiology 30(6), pp. 277-283. (10.1159/000479530)
2017
- Moreno, E. et al. 2017. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.. International Journal of Pharmaceutics 533(1), pp. 236-244. (10.1016/j.ijpharm.2017.09.055)
- Dul, M. et al. 2017. Hydrodynamic gene delivery in human skin using a hollow microneedle device. Journal of Controlled Release 265, pp. 120-131. (10.1016/j.jconrel.2017.02.028)
- Zhao, X., Coulman, S. A., Hanna, S. J., Wong, F. S., Dayan, C. M. and Birchall, J. C. 2017. Formulation of hydrophobic peptides for skin delivery via coated microneedles. Journal of Controlled Release 265, pp. 2-13. (10.1016/j.jconrel.2017.03.015)
- McGrath, M., Coulman, S., Birchall, J. C. and Prausnitz, M. 2017. Editorial. Journal of Controlled Release 265, pp. 1-1. (10.1016/j.jconrel.2017.10.030)
- Jones, B., Ecenarro, S., Whiteside, B., Birchall, J. and Coulman, S. 2017. Imaging techniques for dry powder inhaler capsules. Inhalation
2016
- Shelvey, B., Coulman, S. and John, D. 2016. Evaluating an undergraduate interprofessional education session for medical and pharmacy undergraduates on therapeutics and prescribing: the medical student perspective. Advances in Medical Education and Practice 7, pp. 661-670. (10.2147/AMEP.S116618)
- Czubala, M. A. et al. 2016. TGFβ induces a SAMHD1-independent post-entry restriction to HIV-1 infection of human epithelial Langerhans cells. Journal of Investigative Dermatology 136(10), pp. 1981-1989. (10.1016/j.jid.2016.05.123)
- Chong, R. H., Jones, B., Díez, F., Birchall, J. C. and Coulman, S. 2016. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers. International Journal of Pharmaceutics 500(1-2), pp. 316-325. (10.1016/j.ijpharm.2016.01.034)
- Zhao, X. et al. 2016. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes. Journal of Controlled Release 223, pp. 178-187. (10.1016/j.jconrel.2015.12.040)
2015
- Alhadj Ali, M. et al. 2015. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin. Immunology 146(3), pp. 411-422. (10.1111/imm.12518)
- Alrakaf, S. et al. 2015. An international comparison study of pharmacy students’ achievement goals and their relationship to assessment type and scores. American Journal of Pharmaceutical Education 79(3), pp. 1-8. (10.5688/ajpe79335)
2014
- Griffiths, C. M., Mantzourani, E. D., Poole, R., Tranter, B., Coulman, S. and John, D. N. 2014. Exploring MPharm students’; opinion on a specialist cancer treatment hospital placement. International Journal of Pharmacy Practice 22(S2), pp. 96-97. (10.1111/ijpp.12146)
- Alrakaf, S. et al. 2014. An international validation study of two achievement goal measures in a pharmacy education context. Advances in Medical Education and Practice 2014(5), pp. 339-345. (10.2147/AMEP.S68241)
2013
- Chong, R. et al. 2013. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. Journal of Controlled Release 166(3), pp. 211-219. (10.1016/j.jconrel.2012.12.030)
- Groves, R. B., Coulman, S., Birchall, J. C. and Evans, S. L. 2013. An anisotropic, hyperelastic model for skin: experimental measurements, finite element modelling and identification of parameters for human and murine skin. Journal of the Mechanical Behaviour of Biomedical Materials 18, pp. 167-180. (10.1016/j.jmbbm.2012.10.021)
- Torrisi, B. M., Zarnitsyn, V., Prausnitz, M. R., Anstey, A. V., Gateley, C., Birchall, J. C. and Coulman, S. 2013. Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. Journal of Controlled Release 165(2), pp. 146-152. (10.1016/j.jconrel.2012.11.010)
- Torrisi, B. M., Birchall, J. C., Jones, B., Díez, F. and Coulman, S. 2013. The development of a sensitive methodology to characterise hard shell capsule puncture by dry powder inhaler pins. International Journal of Pharmaceutics 456(2), pp. 545-552. (10.1016/j.ijpharm.2013.08.011)
- Chong, R. H. et al. 2013. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. Journal of Controlled Release 166(3), pp. 211. (10.1016/j.jconrel.2012.12.030)
2012
- Pearton, M., Saller, V., Coulman, S., Gateley, C., Anstey, A. V., Zarnitsyn, V. and Birchall, J. C. 2012. Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression. Journal of Controlled Release 160(3), pp. 561-569. (10.1016/j.jconrel.2012.04.005)
- Groves, R. B., Coulman, S., Birchall, J. C. and Evans, S. L. 2012. Quantifying the mechanical properties of human skin to optimise future microneedle device design. Computer Methods in Biomechanics and Biomedical Engineering 15(1), pp. 73-82. (10.1080/10255842.2011.596481)
2011
- Chong, R., Coulman, S., Saller, V., Pearton, M., Shah, A., Hargest, R. and Birchall, J. C. 2011. Nucleic acid delivery to skin for the potential treatment of dermatopathogenic conditions [Abstract]. Human Gene Therapy 22(10), pp. A82-A82.
- Smith, M. W., Birchall, J. C. and Coulman, S. 2011. The wider contribution of microbiology to the pharmaceutical sciences. In: Denver, S. P. et al. eds. Hugo and Russell's Pharmaceutical Microbiology 8th Edition. Wiley-Blackwell, pp. 463-482.
- Coulman, S. et al. 2011. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharmaceutical Research 28(1), pp. 66-81. (10.1007/s11095-010-0167-x)
- Groves, R. B., Coulman, S., Birchall, J. C. and Evans, S. L. 2011. Using inverse finite element modeling to identify the anisotropic mechanical properties of human and mouse skin in tension. Presented at: International Conference on the Mechanics of Biomaterials and Tissues, Hawaii, USA, 11-15 December 2011.
2010
- Hughes, M. L., Lo, T., Coulman, S., Deslandes, R., Kell, C. and John, D. 2010. What makes a good lecturer? MPharm students’ views. International Journal of Pharmacy Practice 18(s1), pp. 29-30. (10.1111/j.2042-7174.2010.00027.x)
2009
- Ng, K. W. et al. 2009. Development of an ex vivo human skin model for intradermal vaccination: Tissue viability and Langerhans cell behaviour. Vaccine 27(43), pp. 5948-5955. (10.1016/j.vaccine.2009.07.088)
- Ng, K. W. et al. 2009. Tissue viability and Langerhans cell behaviour in an ex-vivo human skin model for cutaneous DNA vaccination [Abstract]. Journal of Pharmacy and Pharmacology 61(S1), pp. A1-A5. (10.1211/002235709789037044)
- Coulman, S. 2009. Targeting the delivery of proteins, DNA and vaccines to the skin [Abstract]. Journal of Pharmacy and Pharmacology 61(S1), pp. A146., article number: 201. (10.1211/002235709789037080)
- Coulman, S., Anstey, A. V., Gateley, C., Morrissey, A., McLoughlin, P., Allender, C. J. and Birchall, J. C. 2009. Microneedle mediated delivery of nanoparticles into human skin. International Journal of Pharmaceutics 366(1-2), pp. 190-200. (10.1016/j.ijpharm.2008.08.040)
- Ng, K. W. et al. 2009. Ex vivo immunological studies using excised human skin. British Journal Of Dermatology 160(4), pp. 921-921.
2006
- Birchall, J. C. et al. 2006. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. International Journal of Pharmaceutics 312(1-2), pp. 15-23. (10.1016/j.ijpharm.2005.12.036)
- Coulman, S. et al. 2006. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Current drug delivery 3(1), pp. 65-75.
- Coulman, S. A. 2006. Gene delivery to human skin using microneedle arrays. PhD Thesis, Cardiff University.
2005
- Birchall, J. C. et al. 2005. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch microfabricated microneedles. Journal of drug targeting 13(7), pp. 415-421. (10.1080/10611860500383705)
Articles
- Moukachar, A. et al. 2023. Development and evaluation of a low‐cost lego 3d bioprinter: from building‐blocks to building blocks of life. Advanced Materials Technologies 8(6), article number: 2100868. (10.1002/admt.202100868)
- Potts, M. R., Evans, S. L., Pullin, R., Coulman, S. A., Birchall, J. C. and Wyatt, H. 2022. An analysis of the relationship between microneedle spacing, needle force and skin strain during the indentation phase prior to skin penetration. Computer Methods in Biomechanics and Biomedical Engineering (10.1080/10255842.2022.2136486)
- Al Dalaty, A., Gualeni, B., Coulman, S. A. and Birchall, J. C. 2022. Models and methods to characterise levonorgestrel release from intradermally administered contraceptives. Drug Delivery and Translational Research 12, pp. 335-349. (10.1007/s13346-021-01091-5)
- Tatovic, D. et al. 2022. Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in Type 1 diabetes. Immunotherapy Advances 2(1), article number: ltac002. (10.1093/immadv/ltac002)
- Gualeni, B. et al. 2021. Human-centred design of a new microneedle-based hormonal contraceptive delivery system [version 2; peer review: 2 approved with reservations]. Gates Open Research 5, article number: 96. (10.12688/gatesopenres.13233.2)
- Singh, R. K. et al. 2021. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides. Nanomedicine: Nanotechnology, Biology and Medicine 32, article number: 102321. (10.1016/j.nano.2020.102321)
- Arikat, F. et al. 2020. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes. Journal of Controlled Release 322, pp. 593-601. (10.1016/j.jconrel.2020.02.031)
- Dul, M. et al. 2019. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy. International Journal of Pharmaceutics 562, pp. 303-312. (10.1016/j.ijpharm.2019.03.041)
- Gualeni, B. et al. 2018. Minimally-invasive and targeted therapeutic cell delivery to the skin using microneedle devices. British Journal of Dermatology 178(3), pp. 731-739. (10.1111/bjd.15923)
- Davies, L., Gateley, C., Holland, P., Coulman, S. and Birchall, J. 2018. Accelerating topical anaesthesia using microneedles. Skin Pharmacology and Physiology 30(6), pp. 277-283. (10.1159/000479530)
- Moreno, E. et al. 2017. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp.. International Journal of Pharmaceutics 533(1), pp. 236-244. (10.1016/j.ijpharm.2017.09.055)
- Dul, M. et al. 2017. Hydrodynamic gene delivery in human skin using a hollow microneedle device. Journal of Controlled Release 265, pp. 120-131. (10.1016/j.jconrel.2017.02.028)
- Zhao, X., Coulman, S. A., Hanna, S. J., Wong, F. S., Dayan, C. M. and Birchall, J. C. 2017. Formulation of hydrophobic peptides for skin delivery via coated microneedles. Journal of Controlled Release 265, pp. 2-13. (10.1016/j.jconrel.2017.03.015)
- McGrath, M., Coulman, S., Birchall, J. C. and Prausnitz, M. 2017. Editorial. Journal of Controlled Release 265, pp. 1-1. (10.1016/j.jconrel.2017.10.030)
- Jones, B., Ecenarro, S., Whiteside, B., Birchall, J. and Coulman, S. 2017. Imaging techniques for dry powder inhaler capsules. Inhalation
- Shelvey, B., Coulman, S. and John, D. 2016. Evaluating an undergraduate interprofessional education session for medical and pharmacy undergraduates on therapeutics and prescribing: the medical student perspective. Advances in Medical Education and Practice 7, pp. 661-670. (10.2147/AMEP.S116618)
- Czubala, M. A. et al. 2016. TGFβ induces a SAMHD1-independent post-entry restriction to HIV-1 infection of human epithelial Langerhans cells. Journal of Investigative Dermatology 136(10), pp. 1981-1989. (10.1016/j.jid.2016.05.123)
- Chong, R. H., Jones, B., Díez, F., Birchall, J. C. and Coulman, S. 2016. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers. International Journal of Pharmaceutics 500(1-2), pp. 316-325. (10.1016/j.ijpharm.2016.01.034)
- Zhao, X. et al. 2016. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes. Journal of Controlled Release 223, pp. 178-187. (10.1016/j.jconrel.2015.12.040)
- Alhadj Ali, M. et al. 2015. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin. Immunology 146(3), pp. 411-422. (10.1111/imm.12518)
- Alrakaf, S. et al. 2015. An international comparison study of pharmacy students’ achievement goals and their relationship to assessment type and scores. American Journal of Pharmaceutical Education 79(3), pp. 1-8. (10.5688/ajpe79335)
- Griffiths, C. M., Mantzourani, E. D., Poole, R., Tranter, B., Coulman, S. and John, D. N. 2014. Exploring MPharm students’; opinion on a specialist cancer treatment hospital placement. International Journal of Pharmacy Practice 22(S2), pp. 96-97. (10.1111/ijpp.12146)
- Alrakaf, S. et al. 2014. An international validation study of two achievement goal measures in a pharmacy education context. Advances in Medical Education and Practice 2014(5), pp. 339-345. (10.2147/AMEP.S68241)
- Chong, R. et al. 2013. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. Journal of Controlled Release 166(3), pp. 211-219. (10.1016/j.jconrel.2012.12.030)
- Groves, R. B., Coulman, S., Birchall, J. C. and Evans, S. L. 2013. An anisotropic, hyperelastic model for skin: experimental measurements, finite element modelling and identification of parameters for human and murine skin. Journal of the Mechanical Behaviour of Biomedical Materials 18, pp. 167-180. (10.1016/j.jmbbm.2012.10.021)
- Torrisi, B. M., Zarnitsyn, V., Prausnitz, M. R., Anstey, A. V., Gateley, C., Birchall, J. C. and Coulman, S. 2013. Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. Journal of Controlled Release 165(2), pp. 146-152. (10.1016/j.jconrel.2012.11.010)
- Torrisi, B. M., Birchall, J. C., Jones, B., Díez, F. and Coulman, S. 2013. The development of a sensitive methodology to characterise hard shell capsule puncture by dry powder inhaler pins. International Journal of Pharmaceutics 456(2), pp. 545-552. (10.1016/j.ijpharm.2013.08.011)
- Chong, R. H. et al. 2013. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. Journal of Controlled Release 166(3), pp. 211. (10.1016/j.jconrel.2012.12.030)
- Pearton, M., Saller, V., Coulman, S., Gateley, C., Anstey, A. V., Zarnitsyn, V. and Birchall, J. C. 2012. Microneedle delivery of plasmid DNA to living human skin: Formulation coating, skin insertion and gene expression. Journal of Controlled Release 160(3), pp. 561-569. (10.1016/j.jconrel.2012.04.005)
- Groves, R. B., Coulman, S., Birchall, J. C. and Evans, S. L. 2012. Quantifying the mechanical properties of human skin to optimise future microneedle device design. Computer Methods in Biomechanics and Biomedical Engineering 15(1), pp. 73-82. (10.1080/10255842.2011.596481)
- Chong, R., Coulman, S., Saller, V., Pearton, M., Shah, A., Hargest, R. and Birchall, J. C. 2011. Nucleic acid delivery to skin for the potential treatment of dermatopathogenic conditions [Abstract]. Human Gene Therapy 22(10), pp. A82-A82.
- Coulman, S. et al. 2011. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharmaceutical Research 28(1), pp. 66-81. (10.1007/s11095-010-0167-x)
- Hughes, M. L., Lo, T., Coulman, S., Deslandes, R., Kell, C. and John, D. 2010. What makes a good lecturer? MPharm students’ views. International Journal of Pharmacy Practice 18(s1), pp. 29-30. (10.1111/j.2042-7174.2010.00027.x)
- Ng, K. W. et al. 2009. Development of an ex vivo human skin model for intradermal vaccination: Tissue viability and Langerhans cell behaviour. Vaccine 27(43), pp. 5948-5955. (10.1016/j.vaccine.2009.07.088)
- Ng, K. W. et al. 2009. Tissue viability and Langerhans cell behaviour in an ex-vivo human skin model for cutaneous DNA vaccination [Abstract]. Journal of Pharmacy and Pharmacology 61(S1), pp. A1-A5. (10.1211/002235709789037044)
- Coulman, S. 2009. Targeting the delivery of proteins, DNA and vaccines to the skin [Abstract]. Journal of Pharmacy and Pharmacology 61(S1), pp. A146., article number: 201. (10.1211/002235709789037080)
- Coulman, S., Anstey, A. V., Gateley, C., Morrissey, A., McLoughlin, P., Allender, C. J. and Birchall, J. C. 2009. Microneedle mediated delivery of nanoparticles into human skin. International Journal of Pharmaceutics 366(1-2), pp. 190-200. (10.1016/j.ijpharm.2008.08.040)
- Ng, K. W. et al. 2009. Ex vivo immunological studies using excised human skin. British Journal Of Dermatology 160(4), pp. 921-921.
- Birchall, J. C. et al. 2006. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. International Journal of Pharmaceutics 312(1-2), pp. 15-23. (10.1016/j.ijpharm.2005.12.036)
- Coulman, S. et al. 2006. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Current drug delivery 3(1), pp. 65-75.
- Birchall, J. C. et al. 2005. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch microfabricated microneedles. Journal of drug targeting 13(7), pp. 415-421. (10.1080/10611860500383705)
Book sections
- Smith, M. W., Birchall, J. C. and Coulman, S. 2011. The wider contribution of microbiology to the pharmaceutical sciences. In: Denver, S. P. et al. eds. Hugo and Russell's Pharmaceutical Microbiology 8th Edition. Wiley-Blackwell, pp. 463-482.
Conferences
- Prytherch, Z. et al. 2018. Evaluation of student engagement with differential media for Flipped Classroom teaching. Presented at: EdMedia: World Conference on Educational Media and Technology, Amsterdam, 25-29 June 2018 Presented at Bastiaens, T. et al. eds.Proceedings of EdMedia: World Conference on Educational Media and Technology. Amsterdam, The Netherlands: Association for the Advancement of Computing in Education (AACE) pp. 1923-1928.
- Groves, R. B., Coulman, S., Birchall, J. C. and Evans, S. L. 2011. Using inverse finite element modeling to identify the anisotropic mechanical properties of human and mouse skin in tension. Presented at: International Conference on the Mechanics of Biomaterials and Tissues, Hawaii, USA, 11-15 December 2011.
Thesis
- Coulman, S. A. 2006. Gene delivery to human skin using microneedle arrays. PhD Thesis, Cardiff University.
Ymchwil
Diddordebau ymchwil
- Y croen yn darged a phorth ar gyfer cyflenwi cyffuriau
- Dyfeisiau micronodwyddo
- Pympiau anadlu powdwr sych sy'n defnyddio capsiwlau
- Y rhyngwyneb defnyddiwr-dyfais
- Bio-argraffu croen dynol
- Cyfrifiadau ar sail rhifedd a meddyginiaethau (ymchwil addysgegol)
Gellir dosbarthu fy arbenigedd a gweithgareddau ymchwil wyddonol yn fras yn dair ffrwd waith, y mae pob un ohonynt yn ymwneud â'r croen (yn organ ac yn rhwystr i’r gwaith o gyflenwi cyffuriau) a/neu optimeiddio systemau cyflenwi cyffuriau arloesol.
Rwyf wedi gweithio gyda dyfeisiau micronodwyddo ers 2002 ac wedi ystyried eu potensial o ran bod yn ffordd llai ymwthiol o gyflenwi cynhwysion fferyllol newydd a chyffredin yn drawsgroenol ac yn fewngroenol. Rwyf hefyd wedi gweithio gydag amrywiaeth o gyffuriau biolegol a brechlynnau. Mae gennyf ddiddordeb angerddol mewn troi’r dechnoleg sy’n sail i brototeipiau labordy’n gynhyrchion sy’n ddefnyddiol yn glinigol ac sydd ar gael yn fasnachol, ac rwy’n canolbwyntio’n benodol ar wneud hyn. Rwyf wedi cyfrannu at amrywiaeth o brosiectau, ac mae gennyf brofiad technegol sylweddol o werthuso systemau cyflenwi mewngroenol a thrawsgroenol, ex vivo ac in vivo. Mae gennyf arbenigedd mewn defnyddio dulliau arloesol o werthuso biofecaneg croen dynol, pensaernïaeth y meinwe ac imiwnoleg leol. Mae fy nghyhoeddiadau hefyd yn rhoi sylw i’r rhain, yn ogystal ag astudiaethau defnyddwyr. Rwy'n un o sefydlwyr Extraject Technologies, cwmni a ddeilliodd o Brifysgol Caerdydd, sy’n ceisio masnacheiddio systemau llai ymwthiol ar gyfer rhoi triniaeth ar sail celloedd i’r croen. Rwyf hefyd yn cyd-gadeirio gweithgor (Patsys â Micronodwyddau – Gweithgor Rheoleiddio; MAP-RWG), a gafodd ei greu yn 2018 er mwyn helpu i ddiffinio’r llwybr ar gyfer rheoleiddio’r math hwn o ddosio a chyflymu’r gwaith o gymhwyso’r dechnoleg yn glinigol.
Rwyf hefyd yn gweithio'n agos gyda Pharma, cwmni rhyngwladol mawr, i werthuso perfformiad cynhyrchion capsiwl cyffredin ac arloesol i’w defnyddio mewn pympiau anadlu powdwr sych sy'n defnyddio capsiwlau. Helpais i ddatblygu methodoleg profi in vitro ar gyfer capsiwlau sydd wedi cael, ac yn dal i gael, ei defnyddio gan y diwydiant fferyllol er mwyn datblygu a sicrhau ansawdd cynhyrchion. Fy nod yw deall a gwella perfformiad pympiau anadlu powdwr sych sy’n defnyddio capsiwlau, yn y labordy ac yn nwylo’r defnyddiwr.
Bio-argraffu 3D ac, yn fwy penodol, fodelu croen drwy ddefnyddio platfform bio-argraffu 3D fforddiadwy sydd ar gael yn fasnachol yw’r trydydd maes sydd o ddiddordeb i mi. Mae'r gwyddonwyr a’r cyhoedd wedi dangos cymaint o ddiddordeb yn y maes ymchwil hynod arloesol hwn, sydd wedi hwyluso nifer o gyfleoedd i ymgysylltu â nhw.
Mae gennyf ddiddordeb addysgegol hefyd mewn cyfrifiadau ar sail rhifedd a meddyginiaethau, ac rwy’n canolbwyntio’n benodol ar addysg myfyrwyr fferyllol a fferyllwyr yn y maes hwn. Rwyf wedi datblygu prawf rhifedd diagnostig cyd-destunol sydd wedi’i ddefnyddio mewn nifer o ysgolion fferylliaeth yn y DU. Rwyf hefyd wedi cyfrannu at weithgareddau sydd wedi dylanwadu’n uniongyrchol ar addysg a hyfforddiant myfyrwyr fferyllol a meddygol.
Addysgu
- PH1000 Datblygiad Proffesiynol
- PH1122 Rôl y Fferyllydd mewn Ymarfer Proffesiynol
- PH1124 Systemau’r Corff Dynol
- PH2000 Datblygiad Proffesiynol
- PH2107 Gwyddoniaeth Fformiwleiddio
- PH3000 Datblygiad Proffesiynol
- PH3110 Optimeiddio Gofal Fferyllol
- PH3202 Methodoleg Ymchwil
- PH4000 Datblygiad Proffesiynol
- PH4116 Prosiect ysgoloriaeth neu ymchwil ym maes fferylliaeth
- PH4118 Gwyddorau Fferyllol, Ymarfer Fferyllol a’r Claf
Arweinydd Asesiadau ac Adborth yr Ysgol Fferylliaeth a Gwyddorau Fferyllol
Arweinydd Cyfrifiadau Fferyllol yr Ysgol Fferylliaeth a Gwyddorau Fferyllol
Bywgraffiad
Proffil gyrfa
Graddiais o Brifysgol Cymru, Caerdydd yn 2001 gyda gradd MPharm ac yna symudais i fy mlwyddyn cyn-cofrestru mewn fferyllfa gymunedol. Yn ystod haf 2002 fe ddes i’n aelod o Gymdeithas Fferyllol Frenhinol Prydain Fawr a dechreuais ymarfer yn broffesiynol yn fferyllydd locwm, gan weithio'n rhan-amser yn y sector cymunedol.
Roedd hyn yn digwydd yr un pryd ag yr oeddwn yn dechrau fy astudiaethau PhD ym Mhrifysgol Caerdydd lle treuliais dair blynedd yn ymchwilio i systemau cyflenwi trawsdermol newydd ar gyfer cyflenwi a mynegi DNA plasmid alldarddol mewn croen dynol. Yn 2005, wrth gwblhau fy astudiaethau PhD, dechreuais ar gontract byr ym Mhrifysgol Caerdydd yn Gymrawd Dysgu ac yn ystod y cyfnod hwn y datblygais fy niddordeb addysgu mewn rhifedd a chyfrifiadau yn seiliedig ar feddyginiaethau, sy’n faes dysgu ac addysgu rwy'n parhau i fod yn angerddol amdano.
Yn ystod haf 2006, ar ôl graddio gyda’m PhD, dechreuais Ddarlithio yn Ysgol Fferylliaeth a Gwyddorau Fferyllol Caerdydd a pharhau i ddilyn fy niddordebau gwyddonol yn y ffordd y defnyddir micronodwyddau i gyflenwi brechlynnau, meddyginiaethau biolegol a nanoronynnau i’r croen. Yn ystod y cyfnod hwn, fe wnes i feithrin perthnasoedd cryf gyda chydweithwyr yn y Gwyddorau Ffisegol a Pheirianneg a datblygais ymagwedd fwy rhyngddisgyblaethol at fy ymchwil, gan fabwysiadu dulliau dadansoddol newydd a modern (er enghraifft, tomograffeg cydlyniad optegol, profi deunyddiau a dadansoddi elfennau meidraidd) o ddisgyblaethau eraill a'u cymhwyso i'm diddordebau ymchwil. Datblygais ddiddordeb hefyd yn y ffordd y defnyddir Anadlyddion sy’n defnyddio Powdwr Sych (DPIs) ar gyfer cyflenwi cyffuriau ysgyfeiniol a chychwynnais weithgareddau ymchwil yn y maes hwn, mewn cydweithrediad â Pharma.
Yn 2014 cefais fy mhenodi’n Uwch Ddarlithydd ac mae gennyf bellach rwydwaith rhyngwladol o gydweithwyr o sefydliadau academaidd, diwydiant, cyrff rheoleiddio a chyrff anllywodraethol. Rwy’n hoff o natur wirioneddol ryngddisgyblaethol y timau yr wyf yn gweithio ynddynt ac yn mwynhau arwain a/neu gyfrannu at ystod o brosiectau, sydd bob un ohonynt yn parhau i fod yn ymwneud â’r croen a datblygiad systemau cyflenwi cyffuriau drwy’r croen neu’n ysgyfeiniol, ac â’u hoptimeiddio a’u perfformiad. Mae fy niddordeb datblygol mewn adeiladu a datblygu bio-argraffydd ar gyfer croen dynol hefyd wedi ysgogi diddordeb y cyhoedd yn fy ngwaith ac wedi arwain at nifer o brofiadau ymgysylltu gwyddonol gydag ystod o gynulleidfaoedd, sy’n rhoi boddhad i mi.
Aelodaeth o gyrff proffesiynol
- Cyd-Gadeirydd y Gweithgor Rheoleiddio Patshys ac ynddynt Ystod o Ficronodwyddau (MAP-RWG)
- Aelod o'r Pwyllgor Llywio ar gyfer y Gynhadledd Ryngwladol ar Ficronodwyddau; Cyd-arweinydd y Gynhadledd Ryngwladol ar Ficronodwyddau 2016
- Aelod Pwyllgor ar gyfer Cymdeithas Rhyddhau Rheoledig y DU ac Iwerddon (UKICRS)
- Aelod o Athrofa Peirianneg a Thrwsio Meinweoedd Caerdydd (CITER)
- Llysgennad STEM
Pwyllgorau ac adolygu
- Pwyllgor Ymgysylltu - Athrofa Peirianneg a Thrwsio Meinwe Caerdydd
Aelodaethau proffesiynol
- Co-Chair of the Microneedle Array Patch-Regulatory Working Group (MAP-RWG)
- Steering Committee Member for the International Conference on Microneedles; Co-host of the International Conference on Microneedles 2016
- Committee Member for the UK and Ireland Controlled Release Society (UKICRS)
- Member of Cardiff Institute of Tissue Engineering and Repair (CITER)
- STEM Ambassador
Pwyllgorau ac adolygu
- Engagement Committee - Cardiff Institute of Tissue Engineering and Repair Learning